$CPMD Cashflow Statement | Understand Stock

$CPMD

$0.00 +$0.00 (0.0%) Close

$CPMD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Amortization of debt discount
Advertising expense paid with common stock
Common stock issued in connection with financing
Depreciation
Impairment of goodwill and long lived assets
Change in the fair value of obligation to issue shares
Interest expense
Net loss
Amortization and depreciation
Change in the fair value of derivative conversion feature
Adjustments for non-cash items:
Loss on impairment of inventory included in cost of goods sold
Shares to be issued for services included in general and administrative
Change in the fair value of derivative conversion feature
Gain on loan dissolution
Change in the fair value of obligation to issue shares
Foreign exchange gain
Interest expense
Imputed interest expense
Loss on the extinguishment of debt
Loss on impairment of investment
Amortization of intangible assets
Stock-based compensation
Stock issued in connection with financing

Goods and services tax receivable
Loss on impairment of investment
Loss on impairment of inventory included in cost of goods sold
Goods and services tax receivable

Loss on impairment of investment
Gain on write-off of accounts payable and accrued liabilities
Other expense
Changes in operating assets and liabilities:
Goods and services tax receivable
Accounts receivable
Prepaid expenses
Inventory
Other assets
Royalty payable
Accounts payable and accrued liabilities
Deferred revenue
Accrued interest
Loan payable related party
Accrued expense related party
Cash used in operating activities
Purchase of fixed assets
Net impact from sale of AMS building excluding mortgage payoff
Purchase of private company equity

Investing activities
Proceeds from the sale of preferred stock
Proceeds from convertible loans
Purchase of equipment
Cash used in investing activities
Effect of exchange rates on cash and cash equivalents

Effects of exchange rates on cash
Financing activities
Acquisition of right-of-use assets for lease obligations
Preferred stock issued as a deposit on an acquisition
Common stock issued for advertising expense
Common stock issued to convert to preferred stock
Cancellation of Series B preferred stock
Common stock issued to convert convertible notes and accrued interest into equity
Common stock issued to convert to Series A preferred stock
Conversion of convertible loans into common stock
Preferred stock and warrants issued for an investment
Promissory notes issued for an investment
Issuance of warrants for convertible notes
Proceeds from notes payable
Proceeds from sale of common stock in private placements
Repayments of related party notes
Common stock issued in connection with financing
Proceeds from loans payable to related parties
Proceeds from convertible notes
Repayments of convertible notes
Cash provided by financing activities

Net change in cash
Cash, beginning of year
Cash, end of year
Supplemental disclosure of cash flow information:
Income tax expense
Cash paid for interest expense
Cash paid for income taxes

Common stock issued as a financing expense on convertible notes
Discount for beneficial conversion feature on convertible notes
Common stock issued related to investment in Great Northern Cannabis
Conversion of convertible notes and accrued interest into common stock
Cancellation of preferred shares Series B
Conversion of convertible loans into common shares
Conversion of preferred shares Series A into common shares
Cash received by related parties directly from customers
Cash paid by related parties directly to suppliers
Reclassification of notes payable to loans payable to related parties
Reclassification of convertible notes to loans payable to related parties
Adjustment for related party loan modification included in additional paid-in capital

Comments